查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466573

3D 列印药品市场：按技术、型态、应用和最终用户划分 - 全球预测 2024-2030

3D Printed Drugs Market by Technology (Direct-Write, Fused Deposition Modelling, Inkjet Printing), Dose Form (Capsule, Nanoparticles, Tablet), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

3D列印药品市场规模预计2023年为2.9272亿美元，2024年达到3.3122亿美元，预计2030年将达到7.4429亿美元，复合年增长率为14.26%。

3D列印药品是指利用3D列印技术生产具有改良的药物传递机制的药品。药品 3D 列印可实现药品製造的个人化、精确性和成本效率。 3D 列印药物的普及正在彻底改变製药业，使设计所需形状、尺寸、剂量和交付速度的药物成为可能，为患者提供个人化的医疗保健。药物发现和开发活动的增加以及对个人化医疗的关注增加了对药物 3D 列印等先进药物製造技术的需求。然而，3D列印技术的初始成本较高，这可能会对3D列印药品的生产产生负面影响。此外，3D列印技术的技术进步有望提高药物生产效率并扩大其在药物开发中的应用。

主要市场统计
基准年[2023] 2.9272亿美元
预测年份 [2024] 33122万美元
预测年份 [2030] 74429万美元
复合年增长率（%） 14.26%

技术直写技术提供个人化且有效的剂量解决方案

3D 列印药物中的直写技术采用精确的薄膜沉积方法来製造结构和成分受控的药物。这种方法可以定製药物配方，从而实现个人化医疗和更有效的药物输送。熔融增材製造（FDM）作为一种广泛使用的3D列印技术，也应用于製药业，以开发3D列印药物。喷墨列印技术已在製药业中应用于3D列印药物，为沉淀药物材料提供了精确且受控的方法。粉末层列印技术在製药业显示出创建客製化和受控药物传输系统的前景。使用光固化成形法技术 3D 列印药物有望创建具有精确剂量的自订控制释放药物。

型态：采用胶囊型3D列印药物的可能性

3D 列印有潜力透过创建针对患者的特定剂量来优化治疗计划。胶囊可以 3D 列印出多个隔间，每个隔间包含不同的药物或剂量，从而促进联合治疗。奈米级 3D 列印可以创建具有控释特性的载药奈米粒子，以优化药物传输。 3D 列印可以将活性药物成分封装在奈米颗粒内，防止它们劣化并确保稳定性。 3D 列印锭剂可以根据每个患者的需求进行定制，从而实现个人化的剂量和治疗计划。 3D 列印能够製造具有复杂几何形状的锭剂，例如影响药物释放动力学的多孔结构和多层设计。

应用扩大在神经治疗药物製造的用途

3D 列印药物将透过提供个人化解决方案（例如客製化对准器、假牙和牙冠）彻底改变牙科产业。客製化的药物输送系统能够针对牙周病等疾病达到精确的药物释放。该技术提高了治疗效果，同时最大限度地减少了副作用。对于人工植牙，3D 列印有助于创建充满药物的支架，从而加速癒合并降低感染疾病风险。在神经病学领域，3D 列印药物对于神经系统疾病的客製化治疗方法至关重要。针对患者的特定药物配方可以实现精确剂量并改善癫痫和神经退化性疾病等疾病的治疗结果。 3D 列印将透过製造患者专用药物和植入来改变整形外科护理。在整形外科药物传输中，3D 列印能够开发适合患者需求的个人化剂型。此外，载药 3D 列印植入可提供受控的局部药物释放，以增强癒合过程、对抗发炎并促进骨再生。

最终使用者：3D列印药物在诊所和医院的渗透

在诊所和医院，医疗专业人员专注于提供个人化药物，青睐根据特定患者需求量身定制的 3D 列印药物。这些 3D 列印药物之所以受到青睐，是因为它们提高了治疗效果，并降低了传统大量生产药物常见的风险和副作用。该实验室正在充分利用 3D 列印药物的精确度和准确度。 3D列印药物使研究人员能够对药物交互作用和药物功效进行具体调查和严格研究。专注于个人化医疗的专科诊所越来越多地使用 3D 列印药物来满足患者的独特需求。个人化药物治疗可根据每位患者独特的生理机能定製药物治疗，从而提高患者的依从性和治疗效率。医生办公室、医院和专科诊所正在广泛采用 3D 列印药物来增强患者治疗通讯协定，而实验室则专注于帮助医疗创新和药物测试的实际好处。

区域洞察

由于医学研发的进步、製药业的强劲以及主要 3D 列印药品製造商的存在，美洲在 3D 列印药品市场中占据关键地位。技术进步的不断进步和医疗基础设施的加强正在进一步推动该地区的市场前景。由于老年人口的增加、个人化医疗的努力、支持性的政府法规以及政府和主要製造商的资助活动，欧洲正在观察 3D 列印药物的重要市场。在中东和非洲，对技术实施和医疗基础设施加固的投资不断增加，促进了市场成长。在快速都市化、医疗技术创新、医疗成本上升以及需要定製药物治疗的老年人口不断增加等因素的推动下，亚太地区正在经历3D列印药品市场的新兴阶段，显示出巨大的成长潜力。

FPNV定位矩阵

FPNV定位矩阵对于评估3D列印医药市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对 3D 列印药品市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.3D列印医药市场的市场规模和预测是多少？

2.在3D列印药品市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.3D列印医药市场的技术趋势和法规结构是什么？

4.3D列印药品市场主要厂商的市场占有率是多少？

5.进入3D列印医药市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对速效药物的需求迅速增加
      • 扩大个人化药物的采用和复杂药物的生产
      • 广泛利用3D列印技术製造癌症治疗药物
    • 抑制因素
      • 与 3D 列印药品製造相关的材料限制
    • 机会
      • 3D列印技术持续技术发展
      • 大量投资生产 3D 列印药品
    • 任务
      • 3D 列印药品製造的复杂性
  • 市场区隔分析
    • 技术：直写技术提供个人化、有效的剂量解决方案
    • 型态：可采用胶囊形式的 3D 列印药物
    • 应用：扩大在神经系统药物製造的应用
    • 最终用户：3D列印药品在诊所和医院的渗透率较高
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第 6 章 3D 列印药品市场：依技术分类

  • 直接写入
  • 熔融沈积法
  • 喷墨印刷
  • 粉红床印刷
  • 立体光刻技术
  • 拉炼剂量

第七章依剂型型态的3D列印药品市场

  • 胶囊
  • 奈米颗粒
  • 药片

第8章 3D列印医药市场：依应用分类

  • 牙科
  • 神经病学
  • 整形外科

第 9 章 3D 列印製药市场：依最终用户分类

  • 诊所和医院
  • 研究室
  • 专科诊所

第10章美洲3D列印药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区3D列印医药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲3D列印药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • CurifyLabs 推出个人化医疗 3D 列印解决方案
    • Cellink 和 Carcinotech 合作透过 3D 生物列印转变癌症药物开发
    • Triastek 的 3D 列印药物治疗溃疡性大肠炎获得 FDA IND核准
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-431C35F6C179

[198 Pages Report] The 3D Printed Drugs Market size was estimated at USD 292.72 million in 2023 and expected to reach USD 331.22 million in 2024, at a CAGR 14.26% to reach USD 744.29 million by 2030.

3D printed drugs refer to the emerging use of 3D printing technology to create pharmaceutical products with improved drug delivery mechanisms. 3D printing of drugs enables personalization, precision, and cost-efficiency in drug manufacturing. The proliferation of 3D printed drugs is transforming the pharmaceutical industry, enabling the design of medications in any desired shape, size, dose, and delivery rate, delivering personalized healthcare for patients. Increased drug discovery and development activities and an inclination towards a personalized medicines approach are raising the need for advanced drug manufacturing techniques such as 3D printing of drugs. However, the high upfront cost of 3D printing technology may adversely impact the production of 3D printed drugs. Moreover, technological advancements in 3D printing technology are expected to enhance drug production efficiency, which is anticipated to expand its use for the development of drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 292.72 million
Estimated Year [2024] USD 331.22 million
Forecast Year [2030] USD 744.29 million
CAGR (%) 14.26%

Technology: Direct-write technology provides personalized and effective medication solutions

Direct-write technology in the context of 3D printed drugs involves using precise deposition methods to create pharmaceutical products with controlled structures and compositions. This approach allows for the customization of drug formulations, enabling personalized medicine and more effective drug delivery. Fused deposition modeling (FDM), a widely used 3D printing technology, has also found application in the pharmaceutical industry to develop 3D-printed drugs. Inkjet printing technology has found applications in the pharmaceutical industry for 3D printing drugs, offering a precise and controlled method for depositing pharmaceutical materials. Powder bed printing technology holds promise in the pharmaceutical industry for creating customized and controlled drug delivery systems. Using stereolithography technology in 3D printing drugs shows promise for creating custom, controlled-release pharmaceuticals with precise dosages.

Dose Form: Potential adoption of 3D printed drugs in the form of capsule

3D printing allows for creating personalized and patient-specific doses, potentially optimizing treatment plans. Capsules can be 3D printed with multiple compartments, each containing a different drug or dosage, facilitating combination therapies. 3D printing at the nanoscale allows for the fabrication of drug-loaded nanoparticles with controlled release properties, optimizing drug delivery. 3D printing can encapsulate active pharmaceutical ingredients within nanoparticles, protecting them from degradation and ensuring stability. Tablets produced through 3D printing can be customized to individual patient needs, allowing for personalized dosages and treatment plans. 3D printing enables the creation of tablets with complex geometries, such as porous structures or multilayered designs, influencing drug release kinetics.

Application: Proliferating use for manufacturing of neurology drugs

3D printed drugs revolutionize dental care by offering personalized solutions such as customized aligners, dentures, and crowns. Customized drug delivery systems enable precise medication release for conditions such as periodontal diseases. This technology enhances treatment efficacy while minimizing side effects. In dental implants, 3D printing facilitates the creation of drug-loaded scaffolds, promoting faster healing and reducing the risk of infections. In neurology, 3D printed drugs are crucial in tailoring treatments for neurological disorders. Patient-specific drug formulations enable precise dosing, enhancing therapeutic outcomes for conditions such as epilepsy and neurodegenerative diseases. 3D printing transforms orthopedic medicine by enabling the fabrication of patient-specific medications and implants. In orthopedic drug delivery, 3D printing allows for development of personalized dosage forms tailored to the patient's needs. Moreover, 3D printed implants with incorporated drugs enhance the healing process, providing controlled and localized drug release to address inflammation and promote bone regeneration.

End-User: Significant penetration of 3D printed drugs in clinics & hospitals

In clinics & hospitals, medical professionals are focusing on delivering personalized medications and prefer 3D printed drugs tailored to meet specific patient needs. These 3D printed drugs are preferred as they increase the effectiveness of treatments and reduce the risks and side effects commonly associated with traditional, mass-produced medications. Research laboratories heavily utilize 3D printed drugs due to their precision and accuracy. 3D printed drugs enable researchers to conduct concrete studies and rigorous research on drug interactions and medicinal effectiveness. Specialty clinics, such as those built around personalized medical treatments, increasingly leverage 3D printed drugs to cater to their unique patient needs. Personalized medication could enhance patient compliance and treatment efficiency since medication could be tailored to each patient's unique physiology. Clinics & hospitals, and special clinics widely adopt 3D printed drugs for enhanced patient treatment protocols, while research laboratories focus on the tangible benefits they provide for medical innovation and drug testing.

Regional Insights

The Americas have a significant landscape in the 3D-printed drugs market owing to progressive medical research and development, the robust pharmaceutical industry, and the presence of key 3D-printed drug manufacturers. Rising technological advancements and enhanced healthcare infrastructure further advance the market landscape in the region. Europe has observed a significant market for 3D printed drugs, driven by a rising geriatric population, initiatives towards personalized medicine, supportive governmental regulations, and funding activities from government and key manufacturers. In the Middle East & Africa, increasing investments in technological adoption and healthcare infrastructure enhancement contribute to market growth. The Asia-Pacific region is witnessing an emerging stage in the 3D printed drugs market and shows significant growth potential driven by factors such as rapid urbanization, innovations in healthcare technologies, increasing healthcare expenditures, and a rising elderly population requiring customized medication.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Printed Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Printed Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Direct-Write
    • Fused Deposition Modelling
    • Inkjet Printing
    • Powder Bed Printing
    • Stereolithography
    • Zip Dose
  • Dose Form
    • Capsule
    • Nanoparticles
    • Tablet
  • Application
    • Dental
    • Neurology
    • Orthopedic
  • End-User
    • Clinics & Hospitals
    • Research Laboratories
    • Speciality Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Printed Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Printed Drugs Market?

3. What are the technology trends and regulatory frameworks in the 3D Printed Drugs Market?

4. What is the market share of the leading vendors in the 3D Printed Drugs Market?

5. Which modes and strategic moves are suitable for entering the 3D Printed Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in demand for instantaneous soluble drugs
      • 5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
      • 5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Constant technological developments in 3D printing technique
      • 5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in manufacturing of 3D printed drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
    • 5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
    • 5.2.3. Application: Proliferating use for manufacturing of neurology drugs
    • 5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. 3D Printed Drugs Market, by Technology

  • 6.1. Introduction
  • 6.2. Direct-Write
  • 6.3. Fused Deposition Modelling
  • 6.4. Inkjet Printing
  • 6.5. Powder Bed Printing
  • 6.6. Stereolithography
  • 6.7. Zip Dose

7. 3D Printed Drugs Market, by Dose Form

  • 7.1. Introduction
  • 7.2. Capsule
  • 7.3. Nanoparticles
  • 7.4. Tablet

8. 3D Printed Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Dental
  • 8.3. Neurology
  • 8.4. Orthopedic

9. 3D Printed Drugs Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinics & Hospitals
  • 9.3. Research Laboratories
  • 9.4. Speciality Clinics

10. Americas 3D Printed Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific 3D Printed Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa 3D Printed Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
    • 13.3.2. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
    • 13.3.3. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. 3D PRINTED DRUGS MARKET DYNAMICS
  • FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 357. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 358. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 359. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 360. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)

TABLE 3